Tech Company Financing Transactions
Enterome Funding Round
Enterome secured a $19 million funding round on 6/12/2025. Investors included Lundbeckfonden BioCapital, Primo Medical Group and Seventure Partners.
Transaction Overview
Company Name
Announced On
6/12/2025
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The new funds will be used to expand and finalize the ongoing Phase 1/2 SIDNEY clinical trial of EO2463 and prepare the candidate for a registrational trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Enterome is a company with the most advanced technology and products in the emerging field of disease management of the human gut microbiome.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pierre Belichard
Chief Financial Officer
Christelle Dumoussaud
Chief Operating Officer
Marie-Laure Bouttier
Chief Scientific Officer
Chrictophe Bonny
VP - Bus. Development
Rodolphe Clerval
Browse more venture capital transactions:
Prev: 6/12/2025: RIIICO venture capital transaction
Next: 6/12/2025: Payrails venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs